Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in IntangiblesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet Equity Issued and RepurchasedNet Income
Growth Metrics
Income Statement
Others
Ratios

CureVac (CVAC) Change in Receivables (2020 - 2024)

Historic Change in Receivables for CureVac (CVAC) over the last 5 years, with Q3 2024 value amounting to $20.1 million.

  • CureVac's Change in Receivables rose 55803.39% to $20.1 million in Q3 2024 from the same period last year, while for Sep 2024 it was $5.6 million, marking a year-over-year increase of 21983.19%. This contributed to the annual value of -$8.7 million for FY2023, which is 18969.88% down from last year.
  • Latest data reveals that CureVac reported Change in Receivables of $20.1 million as of Q3 2024, which was up 55803.39% from -$7.4 million recorded in Q2 2024.
  • In the past 5 years, CureVac's Change in Receivables registered a high of $10.2 billion during Q2 2022, and its lowest value of -$10.7 billion during Q1 2022.
  • For the 5-year period, CureVac's Change in Receivables averaged around -$55.4 million, with its median value being -$2.0 million (2020).
  • Its Change in Receivables has fluctuated over the past 5 years, first surged by 56231701.48% in 2021, then crashed by 45866631.67% in 2022.
  • CureVac's Change in Receivables (Quarter) stood at -$1.6 million in 2020, then skyrocketed by 562317.01% to $8.9 billion in 2021, then crashed by 100.03% to -$2.9 million in 2022, then plummeted by 141.68% to -$7.0 million in 2023, then skyrocketed by 387.91% to $20.1 million in 2024.
  • Its Change in Receivables was $20.1 million in Q3 2024, compared to -$7.4 million in Q2 2024 and -$106463.5 in Q1 2024.